Journal

Journal of Immigrant and Minority Health

Papers (16)

Cervical, Breast, and Colorectal Cancer Screening Outcomes Among Refugees in Philadelphia, Pennsylvania

Abstract Cancer screening can detect cancer at an early stage and decrease cancer morbidity and mortality. Refugee populations may have had limited access to cancer screening before arrival in the United States. A cross-sectional analysis of cervical, breast, and colorectal cancer screening was conducted among refugees with primary care visits between 2018 and 2022 at a refugee health clinic in Philadelphia, Pennsylvania. Cancer screening outcomes included the number and type of screenings; the number of normal, inconclusive, and abnormal screening results; completion of follow-up tests for inconclusive and abnormal results; and the number of cancer diagnoses. Among 149 refugee women aged 21–65, 80.5% were screened for cervical cancer at least once. Among 181 cervical cancer screenings, 89.0% were normal, 3.9% were unsatisfactory, and 7.2% were abnormal. Among 38 refugee women aged 50–74, 92.1% were screened for breast cancer at least once. Among 111 breast cancer screenings, 81.1% were normal, 11.7% were incomplete, and 7.2% were abnormal. Among 107 refugees aged 50–75, 80.4% were screened for colorectal cancer at least once. Among 189 colorectal cancer screenings, 76.2% were normal, 11.1% were inconclusive, and 12.7% were abnormal. There were 0 cancer diagnoses. Longitudinal outcomes beyond the domestic medical exam are valuable to provide insight into cervical, breast, and colorectal cancer screening among refugees in the United States. This could serve as a foundation for future quality improvement interventions to increase cancer screening.

Beyond Knowledge: Trust and the Engagement of Newly Arrived Refugee Women in Cervical Cancer Prevention

Refugee women face unique challenges in accessing preventive healthcare services upon resettlement, particularly for cervical cancer screening and HPV vaccination. Despite national efforts to reduce cervical cancer incidence, uptake remains disproportionately low among newly arrived refugee populations. Emerging research suggests that trust in healthcare systems and providers plays a pivotal role in shaping engagement with these services, yet little is known about how trust is built or broken in the early resettlement period. This study explores how trust and medical mistrust shape cervical cancer prevention behaviors among newly arrived refugee women in the United States, with attention to the multilevel relational and contextual factors that influence screening and vaccination. We conducted in-depth, semi-structured interviews with 17 refugee women resettled within the past two years in a Mid-western City, recruited through a community-based organization. Interviews were conducted in participants' preferred languages and lasted approximately 60 min. Data were thematically analyzed using Braun and Clarke's six-step framework, supported by Dedoose software. A codebook was developed through double coding and refined via consensus meetings. Themes were reviewed collaboratively and verified through member checking to enhance analytical rigor. Participants (n = 17) ranged in age from 21 to 56 and represented five countries, with the majority from Rwanda and Congo. Most had less than a high school education, and nearly all reported limited or no prior knowledge of cervical cancer, Pap smears, or HPV vaccination. Some confused HPV with other illnesses, while others attributed cervical cancer to unrelated factors such as stress or diet. Four themes emerged: trust as a precondition for engagement; provider trust shaped by cultural concordance, communication, and respect; systemic mistrust shaped by health literacy, practical/access issues and social influences; and the importance of community-based relationships in rebuilding trust and supporting preventive care engagement. Refugee women's engagement with cervical cancer prevention is shaped not only by knowledge but also by cultural safety, provider concordance, and systemic trust. Interventions must prioritize community-rooted education, gender-concordant care, and culturally responsive communication to improve prevention outcomes.

Barriers to Breast, Cervical, and Colorectal Cancer Screenings Faced by Refugees Resettled in the United States: A Rapid Review

Abstract Millions of refugees fleeing countries with political unrest and war have been resettled in the United States (U.S.). Although refugees resettled in the U.S. are granted access to health insurance, there are large disparities in the use of preventive health services like cancer screenings between refugees and the native-born population. The U.S. Preventative Services Task Force (USPSTF) recommends screening for breast, cervical, and colorectal cancers, which are highly preventable if detected early. Previous research has investigated barriers to screening for breast, cervical, and colorectal cancers that may underlie screening disparities. However, current reviews assessing these barriers do not distinguish between immigrant and refugee populations and primarily cover breast and cervical cancer screenings. This rapid review aimed to identify barriers to breast, cervical, and colorectal cancer screenings experienced by refugee-specific communities resettled in the U.S. Of the 945 articles retrieved from the database searches, 12 articles were selected for analysis. Data extracted from the selected studies included screening barriers, screening rates, and sample demographics. Six key barrier themes were identified: (1) language and health system navigation, (2) cost, transportation, and time, (3) health knowledge and exposure, (4) fear of cancer screening and diagnosis, (5) cultural and religious beliefs, and (6) refugee experience or status. We noted variations in the screening barriers experienced by different refugee ethnic groups and noted the impact of refugee experiences and trauma in shaping refugee perspectives on screening. The findings of this review suggest the need for interventions aimed at increasing screening rates to consider the nuances in perceived barriers by different refugee ethnic groups and the role of trauma associated with refugee experiences in shaping these barriers.

High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France

AbstractHuman papillomavirus (HPV)-related cervical lesions in first-generation immigrant African women in France should reflect the epidemiology of high-risk (HR)-human papillomavirus (HPV) infection in sub-Saharan Africa. First-generation immigrant African women attending the Centre Hospitalier Régional of Orléans, France, were prospectively subjected to endocervical swabs for HPV DNA PCR and Pap smear. Fifty women (mean age, 41.7 years) living in France (mean stay, 10.7 years) were enrolled, including 26.0% of HIV-negative women from general population and 74.0% of women with known HIV infection. Cervical HPV prevalence was 68.0%, with 56.0% of HR-HPV. HR-HPV -68 and -58 were the predominant genotypes (20.0% and 14.0%, respectively). HR-HPV-16 and HR-HPV-18 were infrequently detected. HIV-infected women showed a trend to be more frequently infected by HPV than HIV-negative women (70.3% versus 61.5%). Most women (84.0%) showed normal cytology, while the remaining (16.0%) exhibited cervical abnormalities and were frequently HIV-infected (87.5%). These observations highlight the unsuspected high burden of cervical HR-HPV infections mostly associated with atypical genotypes, HIV infection and cervical abnormalities in first-generation immigrant African women living in France.

Publisher

Springer Science and Business Media LLC

ISSN

1557-1912